If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email help@ingentaconnect.com

Recurrence of pleomorphic adenoma of the parotid gland—predictive value of cadherin-11 and fascin

$48.00 plus tax (Refund Policy)

Download / Buy Article:

Abstract:

Brieger J, Duesterhoeft A, Brochhausen C, Gosepath J, Kirkpatrick CJ, Mann WJ. Recurrence of pleomorphic adenoma of the parotid gland—predictive value of cadherin-11 and fascin. APMIS 2008;116:1050–7.

The predictive value of cadherin-11, tenascin, fascin, and mucin-1 as markers for the likelihood of recurrence in pleomorphic adenoma of the parotid gland was examined. In this retrospective study we analysed 20 tumours from16 patients by immunohistochemistry. Staining intensities were measured using a semiquantitative scoring approach; localisation (tumour centre vs border) as well as clinical data were analysed and correlated with follow-up. Cadherin-11 was increased in recurrent tumours. However, no changes of fascin, tenascin or mucin-1 were observed. Cadherin-11 and fascin were increased in primary tumours of patients with later recurrence, with fascin upregulation restricted to the tumour border. In conclusion, cadherin-11 and fascin should be further analysed for their value as markers for later recurrence in pleomorphic adenoma. Our observations might reflect dysregulation of cellular pathways contributing to cellular dissemination, which might potentially result in later recurrence.

Keywords: Pleomorphic adenoma; cadherin-11; fascin; mucin-1; parotid gland; tenascin

Document Type: Original Article

DOI: http://dx.doi.org/10.1111/j.1600-0463.2008.01088.x

Affiliations: 1: Department of Otorhinolaryngology, Head and Neck Surgery 2: Institute of Pathology, Johannes Gutenberg University, Mainz, Germany

Publication date: December 1, 2008

Related content

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more